Literature DB >> 11824959

Neonatal lupus manifests as isolated neutropenia and mildly abnormal liver functions.

Sivalingam Kanagasegar1, Rolando Cimaz, Biji T Kurien, Antonio Brucato, R Hal Scofield.   

Abstract

Neonatal lupus is characterized by typical clinical features and the presence of maternal autoantibodies. Mothers can have systemic lupus erythematosus (SLE) or Sjögren's syndrome, but are commonly not affected with any clinical disease. The major clinical manifestations in the infants are cardiac, dermatological and hepatic with rare instances of hemolytic anemia, thrombocytopenia or neutropenia. We describe an infant born to a mother with anti-Ro and anti-La, who had neutropenia and mildly abnormal liver functions without other major clinical features of neonatal lupus such as cardiac or dermatological manifestations. Neutropenia improved as maternal antibody was metabolized. Antibodies from both the infant and mother bound intact neutrophils, and this binding was inhibited by 60 kDa Ro. These data imply neutropenia may be an isolated manifestation of neonatal lupus. We studied the anti-Ro antibodies of 2 other mothers who gave birth to infants with complete congenital heart block and neutropenia. Their sera also bound neutrophils. Because healthy infants do not commonly undergo complete blood counts, the incidence of neutropenia among infants of anti-Ro-positive mothers may be much higher than previously recognized. Furthermore, although other factors may contribute, these data suggest that anti-60 kDa Ro is directly involved in the pathogenesis of neutropenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11824959

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice.

Authors:  Biji T Kurien; Andrew Porter; Yaser Dorri; Saqib Iqbal; Anil D'Souza; Anil Singh; Sima Asfa; Marc Cartellieri; Kristen Mathias; Hiroyuki Matsumoto; Michael Bachmann; Kenneth Hensley; R Hal Scofield
Journal:  Free Radic Biol Med       Date:  2010-10-12       Impact factor: 7.376

Review 2.  Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.

Authors:  Antonio Brucato; Rolando Cimaz; Roberto Caporali; Véronique Ramoni; Jill Buyon
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 3.  Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.

Authors:  Deborah M Friedman; Ann Rupel; Julie Glickstein; Jill P Buyon
Journal:  Indian J Pediatr       Date:  2002-06       Impact factor: 1.967

Review 4.  Neonatal lupus: clinical features and management.

Authors:  Lela A Lee
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

5.  2021 recommendations of the Brazilian Society of Rheumatology for the gynecological and obstetric care of patients with Sjogren's syndrome.

Authors:  Fabiola Reis Oliveira; Valeria Valim; Sandra Gofinet Pasoto; Marilena Leal Mesquita Silvestre Fernandes; Maria Lucia Lemos Lopes; Sonia Cristina de Magalhães Souza Fialho; Aysa César Pinheiro; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lucia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Libório; Maria Carmen Lopes Ferreira Silva Santos; Leandro Tanure; Juliana DAgostino Gennari; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; César Ramos Rocha-Filho; Samira Tatiyama Miyamoto; Lissiane Karine Noronha Guedes; Alisson Pugliesi; Virginia Fernandes Moça Trevisani
Journal:  Adv Rheumatol       Date:  2021-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.